Close Menu

SynapDx

NEW YORK (GenomeWeb News) – SynapDx today announced a deal with Illumina aimed at the detection of autism spectrum disorders.

NEW YORK (GenomeWeb News) – Laboratory Corporation of America is investing $2 million in SynapDx to further its development of an autism spectrum disorder test.

Researchers who set out to compare the ability of SNP and comparative genomic hybridization microarray platforms to detect copy number variation in autusm spectrum disorder managed to identify 16 genes that hadn't been associated with ASD before.

NEW YORK (GenomeWeb News) – SynapDx today announced the completion of a Series A1 financing round that brought in $6 million to support a clinical study in support of the company's test for autism spectrum disorders.

NEW YORK (GenomeWeb News) – In a study appearing online last night in PLoS ONE, researchers from Boston Children's Hospital, Harvard Medical School, and elsewhere reported on a gene expre

The Southborough, Mass.-based startup is using gene-expression arrays to distinguish children with autism from those with other kinds of developmental disorders.

The technology will be used to develop blood-based tests for the early detection of autism spectrum disorders.

Pairings: Jun 30, 2010

Premium

Kamran Alam, Stan Lapidus

Paired Ends: Jun 1, 2010

Premium

Debi Frost, Stan Lapidus

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.